๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST

โœ Scribed by Cunningham, D.; Pople, A.; Ford, H.T.; Hawthorn, J.; Gazet, J.-C.; Challoner, T.; Coombes, R.C.


Book ID
122727763
Publisher
The Lancet
Year
1987
Tongue
English
Weight
456 KB
Volume
329
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


GR38032F, a 5HT3receptor antagonist, in
โœ Michel Marty; Jean P. Droz; Pierre Pouillart; Bernard Paule; Nils Brion; Jacques ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› Springer ๐ŸŒ English โš– 330 KB

A total of 28 patients receiving cancer chemotherapy with cisplatin-containing regimens (70-120 mg/ m 2) participated in an evaluation of the efficacy and safety of GR38032F for the prevention of acute nausea and vomiting. GR38032F, a 5HT3 receptor antagonist, was given 30 min prior to cisplatin as